Vicki Nienaber a scientist with a 30-year career in the biotechnology and pharmaceutical industry. Her pioneering contributions to drug discovery methods and robotics have achieved global recognition and adoption. Renowned for her expertise in computational drug discovery and cheminformatics, she employs AI to predict drug-target interactions and unearth novel therapeutic agents. Currently, she holds the esteemed position of President at both XplorStem and Zenobia Therapeutics.